Once-daily fluocinonide-bifonazole combination for the treatment of vulvar itching and vulvovaginal candidiasis. Preliminary study.
Vulvovaginitis presents a therapeutic challenge. Treatment of vulvovaginal candidiasis with topical imidazole preparations is well accepted. In our work we tested a new cream combining antifungal Bifonazole with a corticosteroid agent (Fluocinonide). The results suggest that most of the patients with vulvovaginitis can benefit from treatment with this new combination cream.
Department of Obst. and Gynecology, Beilinson Medical Center, Petah Tikva, Israel.
B
B
Kaplan
M
M
Royburt
D
D
Rabinerson
A
A
Neri
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D004338:Drug Combinations; D005260:Female; D005447:Fluocinonide / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D009824:Ointments; D016896:Treatment Outcome; D014848:Vulvovaginitis / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D004338:Drug Combinations; D007093:Imidazoles; D009824:Ointments; D005447:Fluocinonide; C036596:bifonazole